MedPath

OLYGOSE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Effect of the Alpha-galacto-oligasaccharides on Weight Loss in Overweight or Moderately Obeses Adults : A Randomized Controlled Double Blinded Trial Versus Placebo

Not Applicable
Completed
Conditions
Randomized Versus Placebo
Controlled
Double Blind
Interventions
Dietary Supplement: Alpha-galacto-oligosaccharides
First Posted Date
2014-08-29
Last Posted Date
2014-08-29
Lead Sponsor
Olygose
Target Recruit Count
100
Registration Number
NCT02228746
Locations
🇫🇷

Centre d'Investigation Clinique Paris-Est/ Bâtiment Antonin Gosset Hôpital de la Pitié Salpêtrière- 56 Boulevard Vincent Auriol, Paris, France

© Copyright 2025. All Rights Reserved by MedPath